New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Shattuck Labs, Inc.
STTK
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

62M

Biotechnology

Next Earning date - 14 Nov 2024

62M

Biotechnology

Next Earning date - 14 Nov 2024

1.30USD
Shape0.06 ( 4.40%)
Market Open
favorite-chart

Relative Strenght

95
favorite-chart

Volume Buzz

-81%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

89%

Quote Panel

Shape
Updated October 22, 2024
1W -10.00 % 1M -64.15 % 3M -70.94 % 1Y -8.74 %

Key Metrics

Shape
  • Market Cap

    62.28M


  • Shares Outstanding

    47.73M


  • Share in Float

    41.28M


  • Dividende

    0


  • Earning Date

    14 Nov 2024


  • Price Target

    1.305


  • Average Volume

    557007


  • Beta

    1.732


  • Range

    1.07-11.76


  • Industry

    Biotechnology


  • Website

    https://www.shattucklabs.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

14.47x

P/S Ratio

0.57x

P/B Ratio

0.0

Debt/Equity

-2068.0%

Net Margin

$-1.9

EPS

How STTK compares to sector?

P/E Ratio

Relative Strength

Shape

STTK

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$1M

Shape-18%

2025-Revenue

$0.97

Shape-132%

2025-EPS

$1M

Shape94%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Needham

downgrade

Previous: Buy

2024-10-02

Now: Hold

Citigroup

downgrade

Previous: Buy

2024-10-01

Now: Neutral

H.C. Wainwright

downgrade

Previous: Buy

2024-10-01

Now: Neutral

H.C. Wainwright

downgrade

Previous: Buy

2024-10-01

Now: Negative

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.58
vs -0.41

Q4.22

arrow
arrow

N/A

-0.60
vs 0.18

Q1.23

arrow
arrow

N/A

-0.49
vs -0.58

Q2.23

arrow
arrow

N/A

-0.50
vs -0.65

Q3.23

arrow
arrow

N/A

-0.65
vs -0.58

Q4.23

arrow
arrow

N/A

-0.41
vs -0.60

Q1.24

arrow
arrow

N/A

-0.37
vs -0.49

Q2.24

arrow
arrow

N/A

-0.42
vs -0.50

Q3.24

arrow
arrow

N/A

-0.42
vs -0.65

Q4.24

arrow
arrow

N/A

-0.35
vs -0.41

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-89%

212K  vs 1.9M

Q4.22

arrow
arrow

-99%

390K  vs 30.1M

Q1.23

arrow
arrow

NA

57K  vs NA

Q2.23

arrow
arrow

+300%

200K  vs 50K

Q3.23

arrow
arrow

+224%

686K  vs 212K

Q4.23

arrow
arrow

+83%

714K  vs 390K

Q1.24

arrow
arrow

+1856%

1.1M  vs 57K

Q2.24

arrow
arrow

+705%

1.6M  vs 200K

Q3.24

arrow
arrow

-5%

652.3K  vs 686K

Q4.24

arrow
arrow

-82%

125K  vs 714K

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-12%

-0.12
vs -0.12

Q4.22

arrow
arrow

-14%

-0.14
vs -0.12

Q1.23

arrow
arrow

-13%

-0.13
vs -0.14

Q2.23

arrow
arrow

-15%

-0.15
vs -0.13

Q3.23

arrow
arrow

-24%

-0.24
vs -0.15

Q4.23

arrow
arrow

-12%

-0.12
vs -0.24

Q1.24

arrow
arrow

-14%

-0.14
vs -0.12

Q2.24

arrow
arrow

-19%

-0.19
vs -0.14

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

62

62
vs 66

-6%

Q4.22

arrow
arrow

48

48
vs 62

-23%

Q1.23

arrow
arrow

49

49
vs 48

2%

Q2.23

arrow
arrow

41

41
vs 49

-16%

Q3.23

arrow
arrow

41

41
vs 41

NA

Q4.23

arrow
arrow

62

62
vs 41

51%

Q1.24

arrow
arrow

73

73
vs 62

18%

Q2.24

arrow
arrow

75

75
vs 73

3%

Earnings Growth

Latest News